...
首页> 外文期刊>European archives of oto-rhino-laryngology: Official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) >Limitations of PET and PET/CT in detecting upper gastrointestinal synchronous cancer in patients with head and neck carcinoma.
【24h】

Limitations of PET and PET/CT in detecting upper gastrointestinal synchronous cancer in patients with head and neck carcinoma.

机译:宠物和PET / CT在头颈癌患者中检测上胃肠同步癌症的局限性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to verify the effectiveness of PET (positron emission tomography) or PET/CT (fusion images of PET with computed tomography) in detecting synchronous cancer in patients with head and neck carcinoma. We reviewed 682 patients with carcinoma of the head and neck between January 2001 and December 2010. In 98 patients, 111 synchronous cancers were diagnosed. Of these 98 patients, the index cancer was predominantly located in the hypopharynx (47 cases), followed by the larynx (23 cases), oropharynx (12 cases) and the oral cavity (6 cases). Esophageal cancer was diagnosed as the most synchronous cancer (57 lesions), followed by gastric cancer (20 lesions), lung cancer (9 lesions) and head and neck cancer (8 lesions). Among these 98 patients, PET or PET/CT was performed in 82 patients. Of these 82 patients, PET or PET/CT detected 34 out of 94 (36.2 %) synchronous cancers. No significant difference was observed between PET and PET/CT in terms of lesion detectability (p = 0.21). Regarding synchronous T1 and Tis upper gastrointestinal (UGI) cancer, PET or PET/CT detected 4 out of 43 (9.3 %) of the cancers. No statistical difference in detectability was observed in patients who underwent PET or PET/CT scanning before or after histological examination of synchronous UGI cancer. In conclusion, synchronous cancer was most frequently observed in the UGI, especially in the esophagus in patients with head and neck carcinoma. PET and PET/CT have limitations in the detection of these lesions.
机译:本研究的目的是验证PET(正电子发射断层扫描)或PET / CT(PET与计算机断层扫描的融合图像)检测头颈癌患者同步癌症的有效性。我们在2001年1月和2010年12月之间审查了682名头部和颈部癌患者。在98例患者中,诊断了111例同步癌症。在这98名患者中,指数癌主要位于低咽喉(47例),其次是喉(23例),Oropharynx(12例)和口腔(6例)。食管癌被诊断为最同步的癌症(57个病变),其次是胃癌(20个病变),肺癌(9个病灶)和头颈癌(8个病灶)。在这98名患者中,在82名患者中进行PET或PET / CT。在这82名患者中,PET或PET / CT检测到94(36.2%)同步癌症中的34个。在病变可检测性方面,PET和PET / CT之间没有观察到显着差异(P = 0.21)。关于同步T1和TIS上胃肠道(UGI)癌症,PET或PET / CT检测到43(9.3%)的癌症中的4个。在同步UGI癌症的组织学检查之前或之后,在接受PET或PET / CT扫描的患者中观察到可检测性的统计差异。总之,UGI最常观察到同步癌,特别是在头部和颈部癌患者的食道中。 PET和PET / CT在检测这些病变时具有局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号